RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @lonaeva: @ArtLeroux @TorquetJ @publicsenat Petit cadeau pour vachier! https://t.co/Kgz0mDlC8O
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @lonaeva: @ArtLeroux @TorquetJ @publicsenat Petit cadeau pour vachier! https://t.co/Kgz0mDlC8O
@ArtLeroux @TorquetJ @publicsenat Petit cadeau pour vachier! https://t.co/Kgz0mDlC8O
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
@Stalec_ @teppdude Ce raporteur cite l'#oms parlons en du panier de crabes de l'#Organisation #Mafieuse de la #Sante ! Lien par ici ⬇️ https://t.co/Kgz0mDlC8O
RT @Nat_anest: Первые два исследования по Ремдесивиру https://t.co/qKzHyeUnpr
RT @Nat_anest: Первые два исследования по Ремдесивиру https://t.co/qKzHyeUnpr
#Gilead_v_HCQ, maker of #Remdesivir, wants to make sure that doctors use their 5-day coronavirus treatment which costs $3,000 per patient. In comparison, a generic dose of #HCQ costs anywhere between $10 and $20. Gilead Remdesevir results are abysmal ht
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
9-11-2020: Has the FDA's recent upgraded approval of remdesivir fooled the doctors? https://t.co/Kj0jDdVec4 https://t.co/EN3FxruBCN https://t.co/HSTXeO6UNW https://t.co/ZEMmihAgLz https://t.co/IUyTSfhF2o https://t.co/YtrFRh2FbH https://t.co/om0pvHLhsa htt
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
RT @MoniquePlaza3: @EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté…
@EChabriere Entre février et mars Yazdan P. avait pu constater que le remdé était toxique pour les reins comme rapporté ici: https://t.co/bZsFJL3Mx6 Sans compter l’étude randomisée de Wang et al, publiée par le Lancet en avril https://t.co/eP1tgHzacC.
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
重度のCOVID-19の成人におけるレンデシビル:無作為化二重盲検プラセボ対照多施設試験 プラセボを早期に中止した患者4人(5%)に対して18人(12%)の患者で有害事象が発生したため、レンデシビルは早期に中止されました。 https://t.co/uwmNlBp3H7
9-10-2020: Members of the NIH receive generous money from Big Pharma, the flawed NIH remdesivir clinical trial should NOT be trusted: https://t.co/YtrFRh2FbH https://t.co/om0pvHLhsa https://t.co/IUyTSfhF2o https://t.co/ZEMmihAgLz https://t.co/nSPlRemTKv h
9-10-2020: The only correct way to compare 2 drugs is one drug alone vs. the other drug alone vs. both drugs combined. The real purpose of this study is to conceal the fact that remdesivir is totally useless https://t.co/j9Jh2Djgx9 https://t.co/iJZZmNHcRJ
9-9-2020: Gilead fears that remdesivir will be tested against other, much more effective drugs against COVID-19. They continue to pretend that their drug can't be made more rapidly: https://t.co/uoexZVGAGr https://t.co/IUyTSfhF2o https://t.co/M6HkkmzeL2
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
@VincentRedon @Tipuncho @OuEstLeBignou @raoult_didier Du coup Remdesivir c'est bien ce dont je me souvenais, pas d'effet ou plutôt quelques effets indésirables... https://t.co/lNifxmilO1 À voir d'autres publis. Mais on peut effectivement s'interroger pq c
RT @MesMitch: But within hours of Fauci’s announcement, the prestigious medical journal The Lancet published results from a study in China…
RT @MesMitch: But within hours of Fauci’s announcement, the prestigious medical journal The Lancet published results from a study in China…
GILD trial focusing on EARLY stage patients (pre-hospitalization). Also a focus on reducing viral load (primary outcome measure) over a period of 7 days. Per this study in the Lancet (late April), IV remdesivir didn't reduce viral load in severe cases ht
@texlaKS @Bmp429 @JordanSchachtel @realDonaldTrump Great document, but no proof that it works. It are just guidelines, and are they still valid? Are they still used? Remdesivir, has been tested 😉 (there are more papers, but i did not investigate this)
9-2-2020:南アフリカの国立保健省は、臨床試験内での使用のみにレムデシビルを推奨する理由として、レムデシビルの高コストと限界利益を挙げて、レムデシビルの使用を推奨しないことを決定しました アビガンジェネリック効果だね✨ #favipiravir
9-2-2020: South Africa's National Health Department has decided not to recommend the use of remdesivir, citing remdesivir's high cost and marginable benefit as reasons to recommend remdesivir only for use inside of clinical trials: https://t.co/j9oLSXMbVU
@EagleFMNam @MhssNamibia @lpm_namibia @Shipululo @mvenaani @EagleFMNam In this study of adult patients admitted to hospital for severe COV19, remdesivir was not associated with statistically significant clinical benefits. Is that why we have to be their
RT @janlotvall: 7/ Sökandet efter läkemedel som stoppar viruset tillväxt i kroppen pågår frenetiskt. #remdesivir har testats kliniskt med v…
RT @janlotvall: 7/ Sökandet efter läkemedel som stoppar viruset tillväxt i kroppen pågår frenetiskt. #remdesivir har testats kliniskt med v…
7/ Sökandet efter läkemedel som stoppar viruset tillväxt i kroppen pågår frenetiskt. #remdesivir har testats kliniskt med varierande resultat. Vi behöver dock veta mer, och hitta fler och säkrare #antivirala läkemedel mot #sarscov2 https://t.co/IcSlEFEGi9
RT @Francis16893780: @banavarrete @harryelsocio https://t.co/OgTHdcAaWy https://t.co/D9lN1gEjDZ In this study of adult patients admitted t…
@banavarrete @harryelsocio https://t.co/OgTHdcAaWy https://t.co/D9lN1gEjDZ In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits. However, the numerical red
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
@YanisJGR Allez une etude sérieuse pour faire rager ces corrompus ! https://t.co/Kgz0mDlC8O
@ArianeWalter Il le semble que le pseudo journaliste scientific Goubet , n'a pas beaucoup publié sur le remdesivir? Petite aide s 'il a des trous de memoire ! https://t.co/Kgz0mDlC8O
8-24-2020: Dr. Swaminathan peer reviews the latest results for remdesivir, which Gilead fraudulently indicates for end-stage COVID-19: https://t.co/AqaMVi0bgI https://t.co/ZEMmihAgLz https://t.co/IUyTSfhF2o https://t.co/DAQHZoyDsD https://t.co/HSTXeO6UNW
@FelipeGarciaGom @_HarDeR__ @GatoCurioso77 @juanrallo No ha demostrado su eficacia contra placebo. Hay casos de mejora, pero no son estadísticamente significativos. En las mascarillas mintió. En esto, no. https://t.co/pAbnA1QZDj
@juanrallo Y aquí en The Lancet sobre pacientes graves y #remdesivir https://t.co/XKCCVtJfcj
A lo mejor si no te dedicases a cuñadear tanto iría mejor la cosa: https://t.co/JhrY51VAdk
@WOrtsen @SimJoeMoore @OHarrysChar @TwitterMoments @zev_dr @tedcruz RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two
@DotsPola @davidmweissman @realDonaldTrump @zev_dr @tedcruz RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two groups i
@VaclavRomanov @davidmweissman @realDonaldTrump @zev_dr @tedcruz RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two gro
@andy_tweetz @taisey13 @StevenCrowtown @TwitterMoments RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two groups in len
@andy_tweetz @richimcmahon @TwitterMoments RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two groups in length of oxyge
@andy_tweetz @BroVic @richimcmahon @TwitterMoments RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two groups in length
@WOrtsen @SimJoeMoore @OHarrysChar @TwitterMoments @zev_dr @tedcruz RCT: "28-day mortality was similar between the two groups (22 [14%] died in the remdesivir group vs 10 (13%) in the placebo group… No significant differences were observed between the two
RT @BakhleD: @DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study rec…
RT @BakhleD: @DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study rec…
RT @BakhleD: @DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study rec…
RT @BakhleD: @DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study rec…
RT @BakhleD: @DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study rec…
@DrSubhasree @Thinkerks @drakchaurasia @AAPSonline @richardursomd @AndrewJacksonV3 @FiatLux_USA @JaspreetSPhoto This study reconfirms the inability of #Remdesivir to add any value like the earlier study from Lancet below: https://t.co/5wpBBPxVr1 There was
@Joaquin_Bob Esta es la Kaplan Meier que muestra beneficio marginal https://t.co/zI5lORM3ho https://t.co/hLa5Deg5Ey
RT @whynotswan: @zev_dr First trial of Remdesivir failed in China. The study ended early not because of lack of patients but because more p…
RT @seleno_glauber: @_Leitadas_Loen @Rconstantino Vou te mandar o link direto pra você não ter trabalho, já que sou desinformado... https:…
RT @whynotswan: @zev_dr First trial of Remdesivir failed in China. The study ended early not because of lack of patients but because more p…
@VickyGMN Los intereses económicos... Aquí te lo dejo... https://t.co/zB2gPnY5wT
RT @whynotswan: @zev_dr First trial of Remdesivir failed in China. The study ended early not because of lack of patients but because more p…
RT @whynotswan: @zev_dr First trial of Remdesivir failed in China. The study ended early not because of lack of patients but because more p…
@Al01828346 @AsierMF @eldiarioes Del ensayo clinico de China https://t.co/zI5lORM3ho
8-21-2020: More bad news from JAMA Network for remdesivir against COVID-19, confirming the negative results from China & New York, U.S. https://t.co/4ns0wtqFqn https://t.co/EN3FxruBCN https://t.co/IUyTSfhF2o https://t.co/ZEMmihAgLz https://t.co/DAQHZo
@_Leitadas_Loen @Rconstantino Vou te mandar o link direto pra você não ter trabalho, já que sou desinformado... https://t.co/c1EK743rNw https://t.co/1dUrdTE7hO https://t.co/ljPG351yTZ https://t.co/GEGMyxCj3V https://t.co/vFZsHpQGuo https://t.co/lc6U
@zev_dr @RonJohnsonWI @SenRonJohnson @SenatorLee @tedcruz "10 (13%) in the placebo group… No significant differences were observed between the two groups in length of oxygen support, hospital length of stay, days from randomisation to discharge, days from
8-20-2020: Cipla takes advantage of black Africa's irrational need to use American-invented drugs by overpricing the useless drug, remdesivir, for South Africa https://t.co/xlvf0d5aN4 https://t.co/om0pvHLhsa https://t.co/DAQHZoyDsD https://t.co/ZEMmihAgLz
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @lonaeva: @DocteurGonzo4 #Oms panier de crabes #Corrompus https://t.co/Kgz0mDlC8O
RT @lonaeva: @DocteurGonzo4 #Oms panier de crabes #Corrompus https://t.co/Kgz0mDlC8O
RT @lonaeva: @DocteurGonzo4 #Oms panier de crabes #Corrompus https://t.co/Kgz0mDlC8O
@DocteurGonzo4 #Oms panier de crabes #Corrompus https://t.co/Kgz0mDlC8O
@gummibear737 Although in China's Remdesivir RCT, mortality benefits were only observed in the earlier subgroup https://t.co/iY2fuJPfhi So, maybe just noise? https://t.co/psavi0akdk